![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by Admin | Apr 25, 2020 | News & Opinions
April 24, 2020 – By Mark Terry – Melbourne, Australia and New York-based Mesoblast Limited announced that in a study of COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS), there was 83% survival with two intravenous...
by Admin | Apr 24, 2020 | News & Opinions
April 24, 2020 / Yimy Villa Dr. John Zaia, City of hope The governing Board of the California Institute for Regenerative Medicine (CIRM) continued its commitment to help with the coronavirus pandemic by awarding $749,999 to Dr. John Zaia at City of Hope. He will be...
by Admin | Apr 21, 2020 | News & Opinions
The RMF team has assembled a google drive folder that contains notable clinical trials related to COVID-19. We will be constantly updating this drive as news about clinical trials is released. There are several folders in the google drive link. Click the link below to...
by Admin | Apr 15, 2020 | News & Opinions
Personalized Stem Cells, Inc. and Calidi Biotherapeutics collaborate to rapidly bring a stem cell therapy into clinical trials for COVID-19 patients. POWAY, CALIFORNIA, USA, April 13, 2020 /EINPresswire.com/ — The scientific community is racing to bring new...
![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by Admin | Apr 9, 2020 | News & Opinions
Dear Friends, We hope that in the midst of these unprecedented times that this message finds you and your loved ones healthy and well. At present – and without hyperbole – our world is faced with crisis that knows no borders, race, or creed. While an...
by Admin | Apr 9, 2020 | News & Opinions
FOR IMMEDIATE RELEASE: APRIL 9, 2020 After a lightning round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of...
